Tidal Investments LLC Makes New $7.63 Million Investment in Tempus AI, Inc. (NASDAQ:TEM)

Tidal Investments LLC bought a new stake in Tempus AI, Inc. (NASDAQ:TEM) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 134,857 shares of the company’s stock, valued at approximately $7,633,000. Tidal Investments LLC owned 0.09% of Tempus AI as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently made changes to their positions in the company. First Horizon Advisors Inc. bought a new stake in shares of Tempus AI in the 3rd quarter valued at about $30,000. Geode Capital Management LLC raised its position in Tempus AI by 0.4% in the 3rd quarter. Geode Capital Management LLC now owns 133,171 shares of the company’s stock valued at $7,537,000 after buying an additional 539 shares during the last quarter. Vestor Capital LLC bought a new stake in shares of Tempus AI in the third quarter worth $153,000. The Manufacturers Life Insurance Company grew its holdings in shares of Tempus AI by 10.2% in the 3rd quarter. The Manufacturers Life Insurance Company now owns 29,789 shares of the company’s stock valued at $1,686,000 after acquiring an additional 2,765 shares in the last quarter. Finally, Stifel Financial Corp bought a new position in Tempus AI in the third quarter valued at approximately $218,000. Institutional investors own 24.22% of the company’s stock.

Tempus AI Price Performance

TEM opened at $41.99 on Friday. The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69. Tempus AI, Inc. has a fifty-two week low of $22.89 and a fifty-two week high of $79.49. The stock’s 50 day simple moving average is $52.88.

Insiders Place Their Bets

In other Tempus AI news, major shareholder Bradley A. Keywell sold 395,800 shares of the stock in a transaction dated Wednesday, December 11th. The stock was sold at an average price of $42.95, for a total transaction of $16,999,610.00. Following the completion of the sale, the insider now directly owns 16,164,449 shares in the company, valued at approximately $694,263,084.55. This trade represents a 2.39 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on the stock. Loop Capital raised their target price on shares of Tempus AI from $48.00 to $57.00 and gave the company a “buy” rating in a research note on Tuesday, October 15th. Bank of America cut shares of Tempus AI from a “buy” rating to a “neutral” rating and upped their target price for the company from $45.00 to $60.00 in a report on Wednesday, October 2nd. Stifel Nicolaus cut Tempus AI from a “buy” rating to a “hold” rating and lifted their price target for the stock from $45.00 to $65.00 in a report on Monday, November 11th. Piper Sandler reaffirmed a “neutral” rating and issued a $70.00 price objective (up from $40.00) on shares of Tempus AI in a research report on Tuesday, November 12th. Finally, Guggenheim initiated coverage on Tempus AI in a report on Monday. They set a “buy” rating and a $74.00 target price on the stock. Three research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $56.20.

Tempus AI Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.